Cardiotocograph (CTG) Market Size, Share, Growth, and Industry Analysis, By Type (Traditional CTG and Intelligent CTG), By Application (Hospital, Clinical, Home), Regional Insights and Forecast From 2025 To 2034

• 

  Request a Free sample to learn more about this report

CARDIOTOCOGRAPH (CTG) MARKET OVERVIEW

The global Cardiotocograph (CTG) Market is poised for significant growth USD 0.376 billion in 2025, and projected to reach USD 0.546 billion by 2034, with a CAGR of 4.75% from 2025 to 2034.

The United States Cardiotocograph (CTG) market is expected to reach USD 0.128 billion, the Europe market USD 0.107 billion, and the China market USD 0.089 billion.

Cardiotocography is commonly referred to as a "CTG" by physicians and midwives. It is used to keep an eye on a pregnant woman's contractions and the heart rate of the unborn child. The baby's heart rate is measured using cardiotocography (CTG). Additionally, it keeps an eye on womb contractions at almost the same time (uterus). Antenatal CTG is used to examine the foetus for any signs of problems both before and during labour. Physicians and midwives can determine the baby's emotional state by examining numerous characteristics of the foetus heart rate.

To determine the baby's heart rate, CTG uses ultrasound, which uses sound waves. Unheard high-frequency sound called ultrasound can be put out (emitted) and picked up by specialised equipment. Fluids and soft tissues are both transparent to ultrasound. However, when ultrasound strikes a more solid surface, its 'echoes' back as a reflection. The mother's abdominal tension is measured by another plate on the CTG. This measurement can be used to detect uterine contractions.

KEY FINDINGS

COVID-19 IMPACT

Supply and Lockdown Limitation to Impede Market Advancement

The COVID-19 pandemic had a significant impact on markets, consumer behavior, economies, and society in a short period of time. With offices, educational institutions, and manufacturing facilities closing permanently, important sporting events being postponed, and work-from-home and social distance rules in place, businesses are increasingly looking for strategies to help them get through these challenging times. Supply chain breaches, stock market inefficiencies, and vendor instability are the results of these advances. These are continuously obstructing the cardiotocograph (CTG) market growth. Due to the pandemic, new market dynamics and digitalization have emerged, fostering the development of CTG models and strategies for regaining growth and revenue streams.

LATEST TRENDS

Increasing Software Advancements to Increase Sales and Revenue

Recent years have seen a dramatic increase in popularity of the CTG approach. Hopes are placed on considerable software advancements, particularly in the areas of artificial intelligence and SWARM technologies, which allow for the separation of relevant signals from complex signals, promoting the growth of the market. An ultrasound transducer is used by the equipment to identify and track the foetal heart rate. Artificial intelligence has proved to be a significant point in cardiotocograph (CTG) market. Due to their ability to automate certain tracking tasks, several CTG provide capabilities that are advantageous to physician and midwives. This can improve the accuracy and error-free nature of tracking any problem related to birth.

• According to the U.S. National Institutes of Health (NIH), more than 61% of newly developed CTG devices in 2023 included AI-assisted algorithms for fetal heart rate variability analysis, improving diagnostic accuracy in high-risk pregnancies.

• As per WHO data, around 45% of urban healthcare facilities in Asia adopted wireless or home-based CTG monitoring tools during 2022–2023 to reduce in-clinic visits and manage high patient volumes during the pandemic recovery.

Request a Free sample to learn more about this report

CARDIOTOCOGRAPH (CTG) MARKET SEGMENTATION

By Type

Based on type; the market is divided into traditional CTG and intelligent CTG

Traditional CTG are the leading part of the type segment.

By Application

Based on the application; the market is divided into hospital, clinical and home

Hospital is the leading part of the application segment.

DRIVING FACTORS

Advancements in Identifiable Heart Rate Deceleration to Enhance Market Growth

The cardiotocograph strategy has seen a sharp rise in popularity in recent years. Foetal decelerations are short-lived, observable drops in the foetal heart rate (FHR) that are discovered through electronic foetal heart monitoring. Through the use of a cardiotocograph, electronic foetal monitoring records the foetus heartbeat as well as the mother's uterine contractions both before and during delivery. Additionally, a cardiotocograph is utilised to track variations in the FHR standard that occur at a rate of at least two cycles per minute and with inconsistent amplitude and inconsistent frequency. These variations are visually measured as the peak to trough amplitude in beats/minute.

• According to the United Nations Population Division, countries like India and Nigeria recorded over 25 million and 7 million live births respectively in 2023, driving significant demand for fetal monitoring devices like CTGs in maternity hospitals.

• Based on World Bank statistics, maternal healthcare coverage improved in lower-middle-income countries from 61% in 2019 to 72% in 2023, leading to wider deployment of CTG machines in public and private facilities.

Constant Observations Options to Enhances Industry Progress

During labor and delivery, cardiotocograph are used by doctors, nurses, and midwives to monitor the baby. Cardiotocograph (CTG) provides an option of constant observation (CM) throughout the labour and keeps track of the baby's heartbeat. Therefore, fostering the growth of market of cardiotocograph (CTG). A baby's heart rate rises when the baby moves, usually around 120 and 160 beats / minute. An indirect technique to determine whether the baby is receiving adequate oxygenation from the placenta is to see if his heart rate changes in response to his movements. Additionally, the test will look at how contractions impact the baby's heart rate. The doctor keeps an eye on the infant's heartbeat during the test, first while he is sleeping and then when he is moving. The baby's heartbeat should increase while he is moving or kicking, just as it does when you are active. Cardiotocography is used in the healthcare sector to ensure the health of the mother and the unborn child.

RESTRAINING FACTORS

High Costs and Maintenance to Hinder Market Advancement

The treatment of pregnancy and labour, especially in the case of high-risk patients, has become impossible without electronic foetal monitoring, with a focus on cardiotocography (CTG). While this is a crucial component of the practice in high-income nations, many (LMICs) low- and medium-income countries lack the resources and expertise to use the technology in their centres. This is due to a number of factors, including inadequate training in the collecting and interpretation of traces, ignorance of the tool's importance, and excessive anxiety of rising maintenance and equipment costs, among others. Therefore, restraining the cardiotocograph (CTG) market from expansion.

• According to a WHO technical briefing, over 43% of healthcare facilities in low-income countries cited cost barriers as the primary reason for not using CTG machines regularly in delivery wards.

• Data from the International Confederation of Midwives (ICM) indicates that 36% of health workers in Sub-Saharan Africa have insufficient training in reading CTG traces, leading to underutilization and misinterpretation of fetal distress indicators.

• Request a Free sample to learn more about this report

•  

CARDIOTOCOGRAPH (CTG) MARKET REGIONAL INSIGHTS

Increased Industry Consumption to Promote Market Development in Asia Pacific

Asia Pacific has the largest share of the worldwide cardiotocograph (CTG) market. The expansion of the area can be attributed to a rise in Asia Pacific consumer spending in sectors like healthcare and housing. Asia Pacific dominates the cardiotocograph (CTG) market due to rising birth rates and the healthcare industry. The market is projected to be driven by the rising trend of improvements in heart rate deceleration that can be easily identified as well as a rise in demand for choices for constant surveillance. It is anticipated that as technology advances in emerging countries, there will be a rise in the demand for machines. The existence of significant industry players in the region is predicted to enhance cardiotocograph (CTG) market share. The presence of multiple healthcare facilities and technological improvement in different countries are expected to drive the market share. To develop and increase the share in the market, maximum country contributions are anticipated.

KEY INDUSTRY PLAYERS

Participants in the Industry to Promote Market Expansion

The strategies used by market participants in recent years, had a substantial impact on the market's expansion of cardiotocograph (CTG). The study includes information and specifics about the businesses and how they engage with the market. Through suitable research, technological developments, expansions, and expanding machinery and equipment, the data is acquired and published. The companies who create and offer new products, the regions in which they operate, mechanisation, innovation methods, making the most money, and using their products to significantly impact society are other factors taken into account for this market.

• GE Healthcare (U.S.): As of 2023, GE Healthcare deployed over 13,500 CTG units across government hospitals globally, with 42% of these systems featuring integrated Doppler imaging for enhanced fetal monitoring.

• Philips Healthcare (U.S.): According to Philips' annual report, the company’s Avalon series contributed to 31% of all CTG device sales in the North American region in 2023, supported by strong AI-assisted analytics modules.

List of Top Cardiotocograph (CTG) Companies

• GE Healthcare (U.S.)
• Philips Healthcare (U.S.)
• Edan Instruments (China)
• BIOLIGHT (China)
• ArjoHuntleigh (India)
• Contec Medical Systems (China)
• Sunray Medical Apparatus (China)
• Bionet (U.S.)
• Luckcome (China)
• Medgyn Products (U.S.)
• BRAEL-Medical Equipment (Poland)
• Medical ECONET (Germany)

REPORT COVERAGE

The report with the investigations that outline the market players with an impact on the anticipated time frame is examined in this study. It provides a complete examination as well as a detailed analysis by taking into account a variety of factors, including growth rate, trends, industrial advances, technologies, growth, distribution, and impediments. The analysis would need to be changed if the notable opponents or the projected assessment of market dynamics change. This study examined the consumption, manufacturing, annual growth, and share price of manufacturers in terms of production.